
Volume 45, Issue 13
1 April 2024
Cover image
Cover image

Fibrosing mediastinitis manifesting as refractory pleural effusion and severe pulmonary hypertension successfully treated by percutaneous pulmonary vein stenting.
ISSN 0195-668X
EISSN 1522-9645
Issue navigation
Volume 45, Issue 13, 1 April 2024
Focus Issue on Interventional Cardiology and Clinical Trials
Issue @ A Glance
Focus on device innovation in interventional cardiology and on trials in cardiovascular prevention
Filippo Crea
European Heart Journal, Volume 45, Issue 13, 1 April 2024, Pages 1089–1093, https://doi.org/10.1093/eurheartj/ehae180
CardioPulse
Ten tips for promoting cardiometabolic health and slowing cardiovascular aging
Maria L Cagigas and others
European Heart Journal, Volume 45, Issue 13, 1 April 2024, Pages 1094–1097, https://doi.org/10.1093/eurheartj/ehad853
Leveraging epitranscriptomics for cardiovascular disease theranostics
Miron Sopic and others
European Heart Journal, Volume 45, Issue 13, 1 April 2024, Pages 1098–1100, https://doi.org/10.1093/eurheartj/ehad852
The 2023 ESC guidelines for the management of cardiomyopathies: the 10 commandments
Juan Pablo Kaski and Elena Arbelo
European Heart Journal, Volume 45, Issue 13, 1 April 2024, Page 1101, https://doi.org/10.1093/eurheartj/ehad858
Weekly Journal Scan
A new RNA-interference based strategy is associated with mild beneficial effects in patients with heart failure due to cardiac amyloidosis
Leonarda Galiuto and Massimo Volpe
European Heart Journal, Volume 45, Issue 13, 1 April 2024, Pages 1102–1103, https://doi.org/10.1093/eurheartj/ehae015
Special Article
Device innovation in cardiovascular medicine: a report from the European Society of Cardiology Cardiovascular Round Table
Stephan Windecker and others
European Heart Journal, Volume 45, Issue 13, 1 April 2024, Pages 1104–1115, https://doi.org/10.1093/eurheartj/ehae069
Fast Track Clinical Research
Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial
Hans Gustav Hørsted Thyregod and others
European Heart Journal, Volume 45, Issue 13, 1 April 2024, Pages 1116–1124, https://doi.org/10.1093/eurheartj/ehae043
Editorial
Transcatheter vs. surgical treatment of aortc stenosis: long awaited long-term data, yet a long way to go
Sabine Bleiziffer
European Heart Journal, Volume 45, Issue 13, 1 April 2024, Pages 1125–1126, https://doi.org/10.1093/eurheartj/ehad873
Clinical Research
Aerobic, resistance, or combined exercise training and cardiovascular risk profile in overweight or obese adults: the CardioRACE trial
Duck-chul Lee and others
European Heart Journal, Volume 45, Issue 13, 1 April 2024, Pages 1127–1142, https://doi.org/10.1093/eurheartj/ehad827
Editorial
A new dawn of managing cardiovascular risk in obesity: the importance of combining lifestyle intervention and medication
Martin Halle and Michael Papadakis
European Heart Journal, Volume 45, Issue 13, 1 April 2024, Pages 1143–1145, https://doi.org/10.1093/eurheartj/ehae091
Clinical Research
Discontinuation vs. continuation of renin–angiotensin system inhibition before non-cardiac surgery: the SPACE trial
Gareth L Ackland and others
European Heart Journal, Volume 45, Issue 13, 1 April 2024, Pages 1146–1155, https://doi.org/10.1093/eurheartj/ehad716
Editorial
Pre-operative withdrawal of renin–angiotensin inhibitors: time to re-visit current guidelines
W Scott Beattie
European Heart Journal, Volume 45, Issue 13, 1 April 2024, Pages 1156–1158, https://doi.org/10.1093/eurheartj/ehad719
Clinical Research
Legacy benefits of blood pressure treatment on cardiovascular events are primarily mediated by improved blood pressure variability: the ASCOT trial
Ajay Gupta and others
European Heart Journal, Volume 45, Issue 13, 1 April 2024, Pages 1159–1169, https://doi.org/10.1093/eurheartj/ehad814
Editorial
Blood pressure variability: no longer a mASCOT for research nerds
Gianfranco Parati and others
European Heart Journal, Volume 45, Issue 13, 1 April 2024, Pages 1170–1172, https://doi.org/10.1093/eurheartj/ehae023
Rapid Communications
Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial
Neila Sayah and others
European Heart Journal, Volume 45, Issue 13, 1 April 2024, Pages 1173–1176, https://doi.org/10.1093/eurheartj/ehad889
Discussion Forum
To transplant or not to transplant ‘marginal’ donor hearts: is machine perfusion the answer?
Jorik H Amesz and others
European Heart Journal, Volume 45, Issue 13, 1 April 2024, Page 1177, https://doi.org/10.1093/eurheartj/ehae062
Machine perfusion of marginal donor hearts: a valuable tool, but where and for whom?
Brian Wayda
European Heart Journal, Volume 45, Issue 13, 1 April 2024, Page 1178, https://doi.org/10.1093/eurheartj/ehae063
Cardiovascular Flashlight
Spontaneous kissing stent for total occlusion of the left main trunk complicated by Stanford Type A aortic dissection
Hidenari Matsumura and others
European Heart Journal, Volume 45, Issue 13, 1 April 2024, Page 1179, https://doi.org/10.1093/eurheartj/ehad830
Fibrosing mediastinitis manifesting as refractory pleural effusion and severe pulmonary hypertension successfully treated by percutaneous pulmonary vein stenting
Ziling He and others
European Heart Journal, Volume 45, Issue 13, 1 April 2024, Page 1180, https://doi.org/10.1093/eurheartj/ehad862
Haemolytic anaemia after transcatheter aortic valve replacement
Kanna Nakamura and others
European Heart Journal, Volume 45, Issue 13, 1 April 2024, Page 1181, https://doi.org/10.1093/eurheartj/ehae010
Correction
Correction to: 2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC)
European Heart Journal, Volume 45, Issue 13, 1 April 2024, Page 1145, https://doi.org/10.1093/eurheartj/ehad870
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals